403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Casebioscience® Joins Team Awarded Up To $7.3 Million By ARPA-H To Advance Ambient Preservation Of Cell Therapies
|
CaseBioscience Inc.
/ Key word(s): Miscellaneous/Agreement
CaseBioscience® Joins Team Awarded Up to $7.3 Million by ARPA-H to Advance Ambient Preservation of Cell Therapies 01.10.2026 / 23:15 CET/CEST The issuer is solely responsible for the content of this announcement. FORT COLLINS, Colo., Oct. 1, 2026 /PRNewswire/ -- CaseBioscience® today announced its participation in a multidisciplinary team led by Likarda that has been awarded up to $7.3 million by the Advanced Research Projects Agency for Health (ARPA-H) through its BioStabilization Systems (BoSS ) program.  The BoSS program aims to foster new technologies to produce, store, and ship cells at room temperature without the need for refrigeration. As the BoSS team states, the goal is to make the most advanced biological medicines as "easy to ship and store as aspirin." Led by Likarda, the Reversible Ambient Biostabilization (RAB) team is one of only three teams selected for the BoSS program. The team brings together expertise spanning preservation science, cell biology, cellular metabolism, bioengineering, immunology, stem cell biology, formulation, and manufacturing. Program at a Glance
  View original content to download multimedia: The issuer is solely responsible for the content of this announcement. The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
2409244 01.10.2026 CET/CEST
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment